|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.68 USD | -8.77% |
|
-6.06% | +17.89% |
| 07-08 | Prime Medicine Receives Favorable Ruling in Beam Therapeutics License Arbitration; Shares Rise | MT |
| 07-08 | Prime Medicine Receives Favorable Ruling in Beam Therapeutics License Arbitration | MT |
| Market Cap | 3.25B 2.85B 2.62B 2.42B 4.6B 310B 4.68B 31.36B 12.31B 153B 12.21B 11.95B 525B | P/E 2026 * |
-7.48x | P/E 2027 * | -7.18x |
|---|---|---|---|---|---|
| Enterprise Value | 2.4B 2.1B 1.93B 1.79B 3.39B 229B 3.45B 23.12B 9.08B 113B 9B 8.81B 387B | EV / Sales 2026 * |
31.7x | EV / Sales 2027 * | 22.8x |
| Free-Float |
98.6% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Beam Therapeutics Inc.
| 1 day | -8.77% | ||
| 1 week | -6.06% | ||
| Current month | -4.78% | ||
| 1 month | +11.12% | ||
| 3 months | +19.14% | ||
| 6 months | +18.62% | ||
| Current year | +17.89% |
| 1 week | 31.34 |  | 38.26 |
| 1 month | 29.1 | | 38.26 |
| Current year | 21.63 | | 38.26 |
| 1 year | 15.6 | | 38.26 |
| 3 years | 13.52 | | 49.5 |
| 5 years | 13.52 | | 116.91 |
| 10 years | 13 | | 138.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Evans
CEO | Chief Executive Officer | 48 | 31/12/2016 |
Sravan Emany
DFI | Director of Finance/CFO | 48 | 18/12/2024 |
| President | 57 | 23/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
John Evans
BRD | Director/Board Member | 48 | 31/12/2016 |
Mark Fishman
BRD | Director/Board Member | 75 | 30/04/2018 |
Graham Cooper
BRD | Director/Board Member | 56 | 09/10/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-29 | Sell | Chief Technology Officer | -373 | 0.0004% | ||
| 06-29 | Fiscal year | Chief Executive Officer | 75,000 | 0.0729% | ||
| 06-25 | F-Prime Inc.
| Sell | Company | -251,488 | 0.2444% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.77% | -6.06% | +54.44% | +2.25% | 3.25B | |
| +0.58% | +2.06% | +3.90% | +10.40% | 50.73B | |
| -2.22% | -1.25% | +391.53% | +591.38% | 39.73B | |
| -0.54% | +0.39% | +27.67% | -3.89% | 34.69B | |
| -1.36% | +0.35% | +19.34% | +58.83% | 33.21B | |
| +1.21% | -4.58% | +3.00% | +37.03% | 26.76B | |
| -1.81% | -1.48% | - | - | 16.8B | |
| +0.51% | -3.47% | +66.38% | +125.61% | 15.37B | |
| +0.23% | -0.58% | +13.80% | +19.56% | 13.78B | |
| -0.62% | -3.09% | +11.43% | -29.93% | 12.85B | |
| Average | -1.28% | -1.35% | +65.72% | +90.14% | 24.72B | |
| Weighted average by Cap. | -0.59% | -0.31% | +82.35% | +124.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 75.74M 66.25M 61.1M 56.44M 107M 7.22B 109M 730M 287M 3.56B 284M 278M 12.23B | 91.37M 79.92M 73.72M 68.09M 129M 8.71B 131M 881M 346M 4.29B 343M 336M 14.76B |
| Net income | -463M -405M -374M -345M -655M -44.16B -666M -4.46B -1.75B -21.75B -1.74B -1.7B -74.79B | -519M -454M -419M -387M -734M -49.49B -746M -5B -1.96B -24.38B -1.95B -1.91B -83.82B |
| Net Debt | -855M -747M -689M -637M -1.21B -81.5B -1.23B -8.24B -3.23B -40.15B -3.21B -3.14B -138B | -1.17B -1.03B -945M -873M -1.66B -112B -1.68B -11.3B -4.44B -55.06B -4.4B -4.3B -189B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | US$32.68 | -8.77% | 2,834,086 |
| 09/07/26 | US$35.82 | -2.87% | 2,508,825 |
| 08/07/26 | US$36.88 | -2.74% | 3,931,070 |
| 07/07/26 | US$37.92 | +7.36% | 3,941,683 |
| 06/07/26 | US$35.32 | +1.52% | 2,404,218 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BEAM Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
